Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers
about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseChaperones in NeurodegenerationRecent advances in quantitative neuroproteomicsMemory loss in Alzheimer's diseaseThe neuroendocrine protein 7B2 is intrinsically disorderedThe neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteinsMonitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicHigh Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal FluidPeptidome analysis of cerebrospinal fluid by LC-MALDI MSInvestigation and reduction of sub-microgram peptide loss using molecular weight cut-off fractionation prior to mass spectrometric analysis.CE-MS for the analysis of intact proteins 2010-2012.MALDI imaging mass spectrometry to investigate endogenous peptides in an animal model of Usher's disease.Potential Biomarker Peptides Associated with Acute Alcohol-Induced Reduction of Blood Pressure.Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease.Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseChanges of Cerebrospinal Fluid Peptides due to Tauopathy.Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?CSF complement 3 and factor H are staging biomarkers in Alzheimer's diseaseCapillary zone electrophoresis as a tool for bottom-up protein analysisA single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity.Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease.Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicityMass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease.Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary NeuronsDeciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing.Neuropeptide VGF Promotes Maturation of Hippocampal Dendrites That Is Reduced by Single Nucleotide Polymorphisms.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.New insight into neurodegeneration: the role of proteomics.CE-ESI-MS for bottom-up proteomics: Advances in separation, interfacing and applications.CE-MS-based proteomics in biomarker discovery and clinical application.Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.Recent developments and applications of capillary and microchip electrophoresis in proteomic and peptidomic analyses.A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
P2860
Q22252572-7941632D-3836-4ABB-BF35-00594F80F4A5Q26782943-099EDF9A-491A-4276-BB6F-72BA3C324F52Q27000073-83096ED5-DF7F-4611-ACF0-67B2CB098B85Q27687485-5CBDA2AD-1C95-4798-A9C2-E08087D46556Q28274203-55635FB5-5233-4FCE-92AF-233ED72D819BQ28279676-A1BC3D4B-6017-4B5F-A919-F193EBA207F1Q28483618-1C5DAEC0-1745-4816-8ED4-B1DE9AD280E5Q28547231-059BD87D-2C4A-4E88-A4C9-EA180A9AE76EQ34374324-94130C02-E264-4DCC-A241-9BE7A75FBA96Q34423522-9A8DFF39-127E-483C-956E-79C4B137702BQ34480662-F4B966D1-2783-41CE-8ACE-816060706C86Q35171092-EF603A3F-3D0F-4F0A-A466-79E46E4DE763Q35905534-B979282A-2B7F-41E6-A9AD-87BE829AD62DQ35948036-DD38FBB8-0F60-4BF0-8290-A24CE8C967C3Q36337525-EEAF0DB6-B90D-4A71-9D31-3064EE7D5C85Q36357894-ECAECA1A-1620-413D-A945-3BD59430EA93Q36539376-E8A84544-D5E5-4201-8298-0512E8E4D1B8Q36539454-E9CDE2A5-B2F0-4D11-A309-EFF474705BD0Q36592268-BCDF7A67-18E7-4C8B-9594-AF57304C05B6Q36608228-2881B3F4-4757-46FA-84CC-926167FAB83FQ36657393-F08C209A-3617-4B2E-B830-8586DD255477Q37181875-6553E3C3-5703-452C-8B02-C50725B69051Q37241399-47A99B67-86D8-4C97-866A-7C7F4CF1B312Q37419731-655EAE7A-3DB4-4E6B-9A8E-7CEAC0CBF605Q37428949-7487C485-4B2E-4A13-B41F-1C76869AE788Q37552845-9C68DAEF-C980-4F84-877B-38EBBB9AB26FQ37625372-350DE5FD-1443-4BD5-B13F-950B5A6685C7Q37699616-DDDF9DFD-3EA2-4149-B375-F1EA8D911CD5Q37718997-45550B56-9606-4821-880C-2D9DA1D37720Q37729262-621580AE-0F15-490D-9BCD-7329D46A9646Q38060574-0AB382C5-2BA9-4882-A547-F911CF12817EQ38091336-19A6E9D7-C75C-4694-8104-C4A854280059Q38130892-6D34855B-9E96-4F5E-8FD6-4ED93E4F35B3Q38170010-D49069A8-FBD8-4CAA-BEFE-77408473BF50Q38213808-3A01B3E7-BE38-4BB6-AD51-9AE08233E91EQ38340358-808CD3DF-0713-4E72-8E7C-A6CADB8AA9B5Q38384848-5ABCEF04-F69F-45B7-8BC6-92639264032AQ38615219-D9564A72-DBCA-43C5-B243-08145C8D1C19Q38644393-9688C432-D283-4821-99EE-FAEB69EE50C8Q38844925-61F3C2A7-93C1-46CF-B21C-34F4FD4B3031
P2860
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@ast
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@en
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@nl
type
label
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@ast
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@en
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@nl
prefLabel
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@ast
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@en
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Peptide fingerprinting of Alzh ...... ion of new synaptic biomarkers
@en
P2093
Klaus Wiedemann
Markus Kellmann
Martin Eichenlaub
Stefan Wittke
Sönke Arlt
Thomas J Raedler
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0026540
P407
P577
2011-01-01T00:00:00Z